With these figures, the Tagesschau has deceived the audience

The Tagesschau of 23 April gave the wrong impression that the final prices of patent-protected medicines in Belgium, the Netherlands and Denmark were almost as high as in Switzerland. And only about 12 percent more expensive than in Sweden. In fact, the price differences are greater. In fact, the Swiss health insurance companies have to spend almost one in four premium francs on medications (including hospital medications). This is by far the Eu…